ENT · Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes)

A 52-year-old male is diagnosed with oropharyngeal squamous cell carcinoma. Immunohistochemistry shows p16 positivity. According to AJCC 8th edition, how does p16-positive status affect the staging of oropharyngeal cancer compared to p16-negative disease?

  • A p16 status does not affect staging but only prognosis
  • B p16-positive tumors are automatically downstaged by one stage group
  • C p16-positive tumors are staged using a separate staging system with different T and N categories
  • D p16-positive tumors are classified as nasopharyngeal carcinoma for staging purposes
Correct answer: C. p16-positive tumors are staged using a separate staging system with different T and N categories

Explanation

AJCC 8th edition introduced separate staging systems for HPV-positive (p16-positive) and HPV-negative oropharyngeal squamous cell carcinoma. The T categories differ (T4 is the highest for HPV-positive, while HPV-negative has T0-T4b), and the N categories are completely different. HPV-positive oropharyngeal cancer has a better prognosis and is staged accordingly, with N1 representing ipsilateral nodes ≤6 cm regardless of number.

Reference: AJCC Cancer Staging Manual, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes) MCQs

See all Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes) MCQs →